Sage Therapeutics

Entity > Corporation > US > New York City New York > Sage Therapeutics

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company dedicated to developing novel therapies that have the potential to transform the lives of people with debilitating brain diseases.

Sage Therapeutics' Specialises in CNS disorders, Neuroscience, Brain Health, Mental Health, and Brain Disorders: With the goal of improving brain health, Sage Therapeutics is breaking new ground. Their depression, neurology and neuropsychiatry franchise programmes aim to change the way brain disorders are viewed and treated.

Sage Therapeutics Has A Distinct Approach to Neuroscience Drug Development: Sage is committed to developing new drugs to treat life-changing brain disorders. Sage Therapeutics conducts clinical trials to determine whether our investigational drugs are safe and effective for patients with a particular disease, disorder or condition, which may enable us to seek the necessary regulatory approvals to provide broad access to these drugs.

Sage Therapeutics' Pipeline: Advancing a Leading Brain Health Portfolio: Sage Therapeutics is committed to addressing patients' unmet treatment needs by advancing product candidates from a robust development pipeline of potential therapies for brain disorders.

Sage Therapeutics' Foundation: Sage Therapeutics was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Sage Therapeutics' Mission and Values: To fearlessly pave the way to a world with better brain health. To pioneer life-changing brain health medicines to help everyone succeed. Sage's goal is to develop meaningful and differentiated drug candidates. They aim to discover new pathways to brain health by developing drugs that matter so patients can get better faster.

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Sage Therapeutics

Company Attribute Value
Address StreetAddress: 215 1st St, AddressLocality: Cambridge, AddressRegion: Massachusetts, PostalCode: 2142, AddressCountry: United States
Founding Date 2010
Name Sage Therapeutics
Number Of Employees 471
Revenue $6,307,000 USD
Ticker Symbol NASDAQ: SAGE
Url sagerx
Facebook facebook
Linkedin linkedin
Twitter twitter
Google google
Wikidata wikidata

Sage Therapeutics

us

New York City, US
22 Jan 2024

New York City, US
22 Jan 2024

Sage Therapeutics

All
News
Images
Maps
Videos
More
Page: 1 Desktop | Laptop Devices

https://www.linkedin.com/company/sage-therapeutics
Sage Therapeutics
https://www.reuters.com › healthcare-pharmaceuticals › s...
Sage Therapeutics to cut about 188 jobs after depression ...
https://finance.yahoo.com › quote › SAGE
Sage Therapeutics, Inc. (SAGE) Stock Price, News, Quote ...
https://twitter.com/SageBiotech?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
Sage Therapeutics (@SageBiotech) · X
https://www.biospace.com › employer › sage-therapeu...
Articles about Sage Therapeutics
https://www.facebook.com/ThisIsSage/
Sage Therapeutics
https://www.cnbc.com › quotes › SAGE
SAGE Therapeutics Inc - Stock Price, Quote and News
Related Searches
Related Searches
Sage therapeutics news
sage therapeutics careers
sage therapeutics layoffs
Knowledge Panel
Knowledge Panel

Sage Therapeutics (Biotech company)

sagerx.com/

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and change how brain disorders are thought about and treated.

linkedin.com/company/sage-therapeutics#:~:text=Sage%20Therapeutics%20is%20a%20biopharmaceutical,are%20thought%20about%20and%20treated.

Related Entities Sage Therapeutics

Entity Home Kalicube Pro Entity Page
Sage Therapeutics Entity Home Sage Therapeutics on Kalicube

Pfizer Entity Home Pfizer on Kalicube

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 93021